BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7539400)

  • 21. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
    Stein R; Chen S; Grossman W; Goldenberg DM
    Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation.
    Irazoqui FJ; Jansson B; Lopez PH; Nores GA
    J Biochem; 2001 Jul; 130(1):33-7. PubMed ID: 11432777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.
    Meichenin M; Rocher J; Galanina O; Bovin N; Nifantev N; Sherman A; Cassagnau E; Heymann MF; Bara J; Fraser RH; Le Pendu J
    Cancer Res; 2000 Oct; 60(19):5499-507. PubMed ID: 11034094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of human tumor associated Thomsen-Friedenreich antigen.
    Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
    Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.
    Trabbic KR; Bourgault JP; Shi M; Clark M; Andreana PR
    Org Biomol Chem; 2016 Apr; 14(13):3350-5. PubMed ID: 26958987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
    Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
    J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.
    Richter DU; Jeschke U; Makovitzky J; Gerber B; Briese V
    Anticancer Res; 2007; 27(4A):2001-3. PubMed ID: 17649812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 N-acetyl-galactosamine).
    Yu LG; Jansson B; Fernig DG; Milton JD; Smith JA; Gerasimenko OV; Jones M; Rhodes JM
    Int J Cancer; 1997 Nov; 73(3):424-31. PubMed ID: 9359491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation.
    Henderson G; Ulsemer P; Schöber U; Löffler A; Alpert CA; Zimmermann-Kordmann M; Reutter W; Karsten U; Goletz S; Blaut M
    Glycobiology; 2011 Oct; 21(10):1277-89. PubMed ID: 21551457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
    Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
    World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
    J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
    Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
    Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of human anti-TF (Thomsen-Friedenreich) and anti-Tn antibodies by affinity chromatography on glycophorin A derivatives and characterization of the antibodies by microtiter plate ELISA.
    Duk M; Lisowska E
    Arch Immunol Ther Exp (Warsz); 1998; 46(2):69-77. PubMed ID: 9613703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
    Dippold W; Steinborn A; Meyer zum Büschenfelde KH
    Environ Health Perspect; 1990 Aug; 88():255-7. PubMed ID: 2272320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen.
    Clausen H; Stroud M; Parker J; Springer G; Hakomori S
    Mol Immunol; 1988 Feb; 25(2):199-204. PubMed ID: 3287140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.
    Hull SR; Bright A; Carraway KL; Abe M; Hayes DF; Kufe DW
    Cancer Commun; 1989; 1(4):261-7. PubMed ID: 2639730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
    Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
    Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
    Heimburg J; Yan J; Morey S; Glinskii OV; Huxley VH; Wild L; Klick R; Roy R; Glinsky VV; Rittenhouse-Olson K
    Neoplasia; 2006 Nov; 8(11):939-48. PubMed ID: 17132226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.